Spyre Therapeutics, Inc.
SYRE • NASDAQ • Stock Fundamentals
Spyre Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Cameron Turtle, with a market cap of $7.0B.
Market Cap$7.0B
Employees30.0
CEOCameron Turtle
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 5, 2026 · 1 month 9 days agoQ1 2026
View reportNext EarningsAug 4, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Spyre Therapeutics, Inc. FAQ
Common questions about Spyre Therapeutics, Inc.
Spyre Therapeutics, Inc. (SYRE) has a market capitalization of $7.0B and trades on NASDAQ.
Spyre Therapeutics, Inc. has approximately 30 employees.